1. The Role of Biologically Active Ingredients from Natural Drug Treatments for Arrhythmias in Different Mechanisms
   Jie Li et al, 2017, BioMed Research International CrossRef
2. Wenxin Keli versus Sotalol for Paroxysmal Atrial Fibrillation Caused by Hyperthyroidism: A Prospective, Open Label, and Randomized Study
   Zhaowei Meng et al, 2015, Evidence-Based Complementary and Alternative Medicine CrossRef
3. The Effect of Wenxin Keli on the mRNA Expression Profile of Rabbits with Myocardial Infarction
   Min Zheng et al, 2016, Evidence-Based Complementary and Alternative Medicine CrossRef
4. miRNA Expression Profile and Effect of Wenxin Granule in Rats with Ligation-Induced Myocardial Infarction
   Aiming Wu et al, 2017, International Journal of Genomics CrossRef
5. Nkx2.5/CARP signaling pathway contributes to the regulation of ion channel remodeling induced by rapid pacing in rat atrial myocytes
   Wei Wang et al, 2016 CrossRef
6. Allicin inhibits transient outward potassium currents in mouse ventricular myocytes
   HONG CAO et al, 2016 CrossRef
7. An integrated anti-arrhythmic target network of a Chinese medicine compound, Wenxin Keli, revealed by combined machine learning and molecular pathway analysis
   Taiyi Wang et al, 2017, Mol. BioSyst. CrossRef
8. Effect of Wenxin Granules on Gap Junction and MiR-1 in Rats with Myocardial Infarction
   Aiming Wu et al, 2017, BioMed Research International CrossRef
9. Wenxin Keli diminishes Ca2+ overload induced by hypoxia/reoxygenation in cardiomyocytes through inhibiting INaL and ICaL
   Antao Luo et al, 2017, Pacing Clin Electrophysiol CrossRef
10. The activation of N-methyl-d-aspartate receptors downregulates transient outward potassium and L-type calcium currents in rat models of depression
    Xin Liu et al, 2017, American Journal of Physiology-Cell Physiology CrossRef
11. Wenxin Keli for Ventricular premature complexes with Heart failure: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Min Li et al, 2017, Complementary Therapies in Medicine CrossRef
12. Wenxin Keli for atrial fibrillation
    Zhuogen He et al, 2018, Medicine CrossRef
13. Recent advances in the treatment of Brugada syndrome
    Mariana Argenziano et al, 2018, Expert Review of Cardiovascular Therapy CrossRef
14. Clinical Safety and Efficacy of Wenxin Keli-Amiodarone Combination on Heart Failure Complicated by Ventricular Arrhythmia: A Systematic Review and Meta-analysis
    Rui Zheng et al, 2018, Front. Physiol. CrossRef
15. Therapeutic Effects of Wenxin Keli in Cardiovascular Diseases: An Experimental and Mechanism Overview
    Guihua Tian et al, 2018, Front. Pharmacol. CrossRef
16. Chronic stimulation of the sigma-1 receptor ameliorates autonomic nerve dysfunction and atrial fibrillation susceptibility in a rat model of depression
    Xin Liu et al, 2018, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
17. Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation
    Nixiao Zhang et al, 2018, Cardiology Research and Practice CrossRef
18. Mechanisms underlying atrial-selective block of sodium channels by Wenxin Keli: Experimental and theoretical analysis
    Dan Hu et al, 2016, International Journal of Cardiology CrossRef
19. Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome
    Yoshino Minoura et al, 2013, Heart Rhythm CrossRef
20. Cerebrospinal fluid pharmacology: an improved pharmacology approach for chinese herbal medicine research.
    Yan-Qing Wu et al, 2013, Evid Based Complement Alternat Med CrossRef
21. Effects of Wenxin Keli on the Action Potential and L-Type Calcium Current in Rats with Transverse Aortic Constriction-Induced Heart Failure
    Yu Chen et al, 2013, Evidence-Based Complementary and Alternative Medicine CrossRef
22. J-wave syndromes: Brugada and early repolarization syndromes.
    Charles Antzelevitch et al, 2015, Heart Rhythm CrossRef
23. Novel therapeutic strategies for the management of ventricular arrhythmias associated with the Brugada syndrome
    Bence Patocskai et al, 2015, Expert Opinion on Orphan Drugs CrossRef
24. Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects
    Charles Antzelevitch et al, 2016, Current Problems in Cardiology CrossRef
25. The Role of Traditional Chinese Herbal Medicines and Bioactive Ingredients on Ion Channels: A Brief Review and Prospect
    Yian Huang et al, 2019, CNSNDDT CrossRef
26. Comparative metabonomics of Wenxin Keli and Verapamil reveals differential roles of gluconeogenesis and fatty acid β-oxidation in myocardial injury protection
    Miaomiao Jiang et al, 2017, Sci Rep CrossRef
27. Identification of Target Genes of Antiarrhythmic Traditional Chinese Medicine Wenxin Keli
    Yusi Yao et al, 2020, Cardiovascular Therapeutics CrossRef
28. Over-expression of microRNA-145 drives alterations in β-adrenergic signaling and attenuates cardiac remodeling in heart failure post myocardial infarction
    Zhebo Liu et al, 2020, Aging CrossRef
29. Pharmacological Therapy in Brugada Syndrome
    Oholi Tovia Brodie et al, 2018 CrossRef
30. Wenxin Keli for the Treatment of Arrhythmia—Systems Pharmacology and In Vivo Pharmacological Assessment
    Xiaofeng Li et al, 2021, Front. Pharmacol. CrossRef
31. Mechanism-based targeting of cardiac arrhythmias by phytochemicals and medicinal herbs: A comprehensive review of preclinical and clinical evidence
    Danesh Soltani et al, 2022, Front. Cardiovasc. Med. CrossRef
32. Chinese herbal medicine for the treatment of cardiovascular diseases ─ targeting cardiac ion channels
    Zhenzhen Yan et al, 2023, Pharmacological Research CrossRef
33. Protective effects of Wenxin Keli against cardiac arrhythmias (Review)
    Shristi Dahal et al, 2020, World Acad Sci J CrossRef
34. Identification of Lauric Acid as a Potent Sodium Channel NaV1.5 Blocker from Compound Chinese Medicine Wenxin Keli
    Weiwei Xie et al, 2025, DDDT CrossRef